2 completed, 1 active not recruiting, 1 recruiting. 4 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 2, Active not recruiting 1, Recruiting 1 |
Follow Cardiovascular: new trials by email Literature Review of Cardiovascular trials Research Report on Cardiovascular
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias CTX310 - Cardiovascular, Metabolic Disease | Phase 1 | Recruiting | CRISPR Therapeutics AG | 90 | 2024-06-21 | 2026-09-18 |
| A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD1705 in Participants With Dyslipidemia AZD1705, Placebo - Cardiovascular | Phase 1 | Active not recruiting | AstraZeneca | 98 | 2024-01-16 | 2026-08-05 |
| AMG 529 First in Human Study AMG 529, Placebo - Cardiovascular | Phase 1 | Completed | Amgen | 48 | 2017-05-15 | 2019-07-05 |
| A Study to Evaluate Cardiovascular Interactions Between Mirabegron and Tamsulosin mirabegron, tamsulosin - Cardiovascular, Healthy Subjects | Phase 1 | Completed | Astellas Pharma Inc | 48 | 2010-08-01 | 2013-12-09 |
Dyslipidemias (2) · Homozygous Familial Hypercholesterolemia (1) · Hypercholesterolemia (1) · Hyperlipoproteinemia Type V (1) · Hypertriglyceridemia (1) · Lipid Metabolism Disorders (1) · Metabolic Diseases (1)
Nutritional and Metabolic Diseases (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Genetic Diseases, Inborn (1) · Hyperlipidemias (1) · Hyperlipoproteinemia Type II (1) · Hyperlipoproteinemias (1) · Lipid Metabolism Disorders (1) · Lipid Metabolism, Inborn Errors (1) · Metabolic Diseases (1) · Metabolism, Inborn Errors (1)
Tamsulosin (1) · mirabegron (1)
Amgen (1) · Astellas Pharma Inc (1) · AstraZeneca (1) · CRISPR Therapeutics AG (1)
United States (3) · United Kingdom (2) · Australia (1) · New Zealand (1)